HFDs significantly increase hepatic SREBP-1c activity, leading to enhanced triglyceride synthesis and lipid accumulation, contributing to NAFLD, insulin resistance, and obesity-related inflammation [80]. This evidence concerns the gene SREBF1 and metabolic dysfunction-associated steatotic liver disease.